Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options
placeholder image
Publications in VIVO
 
    Export Publications Table
co-author
Co-author Network
map of science
Map of Science

Mueller, B. M.

share the uri
  • Publications
scroll to property group menus

Publications

recent publications

  • academic article

    • Miles, L. A., Lighvani, S., Baik, N., Parmer, C. M., Khaldoyanidi, S., Mueller, B. M., Parmer, R. J. New insights into the role of Plg-RKT in macrophage recruitment International Review of Cell and Molecular Biology  2014 309:259-302  DOI:10.1016/b978-0-12-800255-1.00005-3  PMID:24529725
    • Schaffner, F., Yokota, N., Carneiro-Lobo, T., Kitano, M., Schaffer, M., Anderson, G. M., Mueller, B. M., Esmon, C. T., Ruf, W. Endothelial protein C receptor function in murine and human breast cancer development PLoS One  2013 8:e61071  DOI:10.1371/journal.pone.0061071  PMID:23593394  PMCID:PMC3621887
    • Schaffner, F., Versteeg, H. H., Schillert, A., Yokota, N., Petersen, L. C., Mueller, B. M., Ruf, W. Cooperation of tissue factor cytoplasmic domain and par2 signaling in breast cancer development Blood  2010 116:6106-6113  DOI:10.1182/blood-2010-06-289314  PMID:20861457  PMCID:PMC3031395
    • Versteeg, H. H., Schaffner, F., Kerver, M., Ellies, L. G., Andrade-Gordon, P., Mueller, B. M., Ruf, W. Protease-activated receptor (par) 2, but not par1, signaling promotes the development of mammary adenocarcinoma in polyoma middle t mice Cancer Research  2008 68:7219-7227  DOI:10.1158/0008-5472.can-08-0419  PMID:18757438  PMCID:PMC2596617
    • Versteeg, H. H., Schaffner, F., Kerver, M., Petersen, H. H., Ahamed, J., Felding-Habermann, B., Takada, Y., Mueller, B. M., Ruf, W. Inhibition of tissue factor signaling suppresses tumor growth Blood  2008 111:190-199  DOI:10.1182/blood-2007-07-101048  PMID:17901245  PMCID:PMC2200804
    • Uusitalo-Jarvinen, H., Kurokawa, T., Mueller, B. M., Andrade-Gordon, P., Friedlander, M., Ruf, W. Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis Arteriosclerosis, Thrombosis, and Vascular Biology  2007 27:1456-1462  DOI:10.1161/atvbaha.107.142539  PMID:17363687
    • Ahamed, J., Versteeg, H. H., Kerver, M., Chen, V. M., Mueller, B. M., Hogg, P. J., Ruf, W. Disulfide isomerization switches tissue factor from coagulation to cell signaling Proceedings of the National Academy of Sciences of the United States of America  2006 103:13932-13937  DOI:10.1073/pnas.0606411103  PMID:16959886  PMCID:PMC1599891
    • Guo, F., Das, S., Mueller, B. M., Barbas, C. F., Lerner, R. A., Sinha, S. C. Breaking the one antibody-one target axiom Proceedings of the National Academy of Sciences of the United States of America  2006 103:11009-11014  DOI:10.1073/pnas.0603822103  PMID:16822849  PMCID:PMC1488731
    • Ruf, W., Mueller, B. M. Thrombin generation and the pathogenesis of cancer Seminars in Thrombosis and Hemostasis  2006 32:61-68  DOI:10.1055/s-2006-939555  PMID:16673267
    • Jessani, N., Niessen, S., Mueller, B. M., Cravatt, B. F. Breast cancer cell lines grown in vivo: What goes in isn't always the same as what comes out Cell Cycle  2005 4:253-255  PMID:15655359
    • Jessani, N., Humphrey, M., McDonald, W. H., Niessen, S., Masuda, K., Gangadharan, B., Yates, J. R., 3rd, Mueller, B. M., Cravatt, B. F. Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo Proceedings of the National Academy of Sciences of the United States of America  2004 101:13756-13761  DOI:10.1073/pnas.0404727101  PMID:15356343  PMCID:PMC518829
    • Shi, X. L., Gangadharan, B., Brass, L. F., Ruf, W., Mueller, B. M. Protease-activated receptors (par1 and par2) contribute to tumor cell motility and metastasis Molecular Cancer Research  2004 2:395-402  PMID:15280447
    • Belting, M., Dorrell, M. I., Sandgren, S., Aguilar, E., Ahamed, J., Dorfleutner, A., Carmeliet, P., Mueller, B. M., Friedlander, M., Ruf, W. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling Nature Medicine  2004 10:502-509  DOI:10.1038/nm1037  PMID:15098027
    • Riewald, M., Petrovan, R. J., Donner, A., Mueller, B. M., Ruf, W. Activation of endothelial cell protease activated receptor 1 by the protein c pathway Science  2002 296:1880-1882  DOI:10.1126/science.1071699  PMID:12052963
    • Felding-Habermann, B., O'Toole, T. E., Smith, J. W., Fransvea, E., Ruggeri, Z. M., Ginsberg, M. H., Hughes, P. E., Pampori, N., Shattil, S. J., Saven, A., Mueller, B. M. Integrin activation controls metastasis in human breast cancer Proceedings of the National Academy of Sciences of the United States of America  2001 98:1853-1858  DOI:10.1073/pnas.98.4.1853  PMID:11172040  PMCID:PMC29346
    • Ott, I., Miyagi, Y., Miyazaki, K., Heeb, M. J., Mueller, B. M., Rao, L. V. M., Ruf, W. Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor Arteriosclerosis, Thrombosis, and Vascular Biology  2000 20:874-882  PMID:10712416
    • Ruf, W., Fischer, E. G., Huang, H. Y., Miyagi, Y., Ott, I., Riewald, M., Mueller, B. M. Diverse functions of protease receptor tissue factor in inflammation and metastasis Immunologic Research  2000 21:289-292  DOI:10.1385/ir:21:2-3:289  PMID:10852129
    • Fischer, E. G., Riewald, M., Huang, H. Y., Miyagi, Y., Kubota, Y., Mueller, B. M., Ruf, W. Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor Journal of Clinical Investigation  1999 104:1213-1221  DOI:10.1172/jci7750  PMID:10545520
    • Ruf, W., Mueller, B. M. Tissue factor signaling Thrombosis and Haemostasis  1999 82:175-182  PMID:10605702
    • Dolman, C. S., Mueller, B. M., Lode, H. N., Xiang, R., Gillies, S. D., Reisfeld, R. A. Suppression of human prostate carcinoma metastases in severe combined immunodeficient mice by interleukin 2 immunocytokine therapy Clinical Cancer Research  1998 4:2551-2557  PMID:9796990
    • Mueller, B. M., Ruf, W. Requirement for binding of catalytically active factor viia in tissue factor-dependent experimental metastasis Journal of Clinical Investigation  1998 101:1372-1378  DOI:10.1172/jci930  PMID:9525979
    • Ott, I., Fischer, E. G., Miyagi, Y., Mueller, B. M., Ruf, W. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280 Journal of Cell Biology  1998 140:1241-1253  DOI:10.1083/jcb.140.5.1241  PMID:9490735
    • Wong, N. C., Mueller, B. M., Barbas, C. F., Ruminski, P., Quaranta, V., Lin, E. C. K., Smith, J. W. Alpha(v) integrins mediate adhesion and migration of breast carcinoma cell lines Clinical & Experimental Metastasis  1998 16:50-61  PMID:9502077
    • Sivam, G. P., Martin, P. J., Reisfeld, R. A., Mueller, B. M. Therapeutic efficacy of a doxorubicin immunoconjugate in a preclinical model of spontaneous metastatic human-melanoma Cancer Research  1995 55:2352-2356  PMID:7757986
    • Fischer, E. G., Ruf, W., Mueller, B. M. Tissue factor-initiated thrombin generation activates the signaling thrombin receptor on malignant-melanoma cells Cancer Research  1995 55:1629-1632  PMID:7712465
    • Montgomery, A. M. P., Mueller, B. M., Reisfeld, R. A., Taylor, S. M., Declerck, Y. A. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human-melanoma cell-line Cancer Research  1994 54:5467-5473  PMID:7923181
    • Sabzevari, H., Gillies, S. D., Mueller, B. M., Pancook, J. D., Reisfeld, R. A. A recombinant antibody interleukin-2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency mice Proceedings of the National Academy of Sciences of the United States of America  1994 91:9626-9630  DOI:10.1073/pnas.91.20.9626  PMID:7937818
    • Naramura, M., Gillies, S. D., Mendelsohn, J., Reisfeld, R. A., Mueller, B. M. Mechanisms of cellular cytotoxicity mediated by a recombinant antibody il2 fusion protein against human-melanoma cells Immunology Letters  1993 39:91-99  DOI:10.1016/0165-2478(93)90169-3  PMID:8144194
    • Naramura, M., Gillies, S. D., Mendelsohn, J., Reisfeld, R. A., Mueller, B. M. Therapeutic potential of chimeric and murine anti-(epidermal growth-factor receptor) antibodies in a metastasis model for human-melanoma Cancer Immunology Immunotherapy  1993 37:343-349  DOI:10.1007/bf01518458  PMID:8402738
    • Montgomery, A. M. P., Declerck, Y. A., Langley, K. E., Reisfeld, R. A., Mueller, B. M. Melanoma-mediated dissolution of extracellular-matrix - contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways Cancer Research  1993 53:693-700  PMID:8425205
    • Mueller, B. M., Reisfeld, R. A., Edgington, T. S., Ruf, W. Expression of tissue factor by melanoma-cells promotes efficient hematogenous metastasis Proceedings of the National Academy of Sciences of the United States of America  1992 89:11832-11836  DOI:10.1073/pnas.89.24.11832  PMID:1465406
    • Schrappe, M., Bumol, T. F., Apelgren, L. D., Briggs, S. L., Koppel, G. A., Markowitz, D. D., Mueller, B. M., Reisfeld, R. A. Long-term growth suppression of human glioma xenografts by chemoimmunoconjugates of 4-desacetylvinblastine-3-carboxyhydrazide and monoclonal-antibody 9.2.27 Cancer Research  1992 52:3838-3844  PMID:1617657
    • Feldinghabermann, B., Mueller, B. M., Romerdahl, C. A., Cheresh, D. A. Involvement of integrin alpha V gene expression in human melanoma tumorigenicity Journal of Clinical Investigation  1992 89:2018-2022  DOI:10.1172/jci115811  PMID:1376331  PMCID:PMC295910
    • Haenseler, E., Esswein, A., Vitols, K. S., Montejano, Y., Mueller, B. M., Reisfeld, R. A., Huennekens, F. M. Activation of methotrexate-alpha-alanine by carboxypeptidase-A monoclonal-antibody conjugate Biochemistry  1992 31:891-897  DOI:10.1021/bi00118a035  PMID:1731945
    • Sanders, L. C., Feldinghabermann, B., Mueller, B. M., Cheresh, D. A. Role of alpha V integrins and vitronectin in human melanoma cell growth Cold Spring Harbor Symposia on Quantitative Biology  1992 57:233-240  PMID:1285050
    • Mueller, B. M., Reisfeld, R. A. Potential of the scid mouse as a host for human tumors Cancer and Metastasis Reviews  1991 10:193-200  DOI:10.1007/bf00050791  PMID:1764764
    • Reisfeld, R. A., Mueller, B. M., Schrappe, M., Wargalla, U., Yang, H. M., Wrasidlo, W. Antibody-drug conjugates for cancer therapy: promises and problems Immunology and Allergy Clinics of North America  1991 11:341-358
    • Mueller, B. M., Romerdahl, C. A., Trent, J. M., Reisfeld, R. A. Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth-factor receptor Cancer Research  1991 51:2193-2198  PMID:2009538
    • Dorai, H., Mueller, B. M., Reisfeld, R. A., Gillies, S. D. Aglycosylated chimeric mouse human iggl antibody retains some effector function Hybridoma  1991 10:211-217  DOI:10.1089/hyb.1991.10.211  PMID:1874515
    • Barker, E., Mueller, B. M., Handgretinger, R., Herter, M., Yu, A. L., Reisfeld, R. A. Effect of a chimeric antiganglioside gd2 antibody on cell-mediated lysis of human neuroblastoma-cells Cancer Research  1991 51:144-149  PMID:1988079
    • Mueller, B. M., Reisfeld, R. A., Silveira, M. H., Duncan, J. D., Wrasidlo, W. A. Preclinical therapy of human-melanoma with morpholino-doxorubicin conjugated to a monoclonal-antibody directed against an integrin on melanoma-cells Antibody Immunoconjugates and Radiopharmaceuticals  1991 4:99-106
    • Mueller, B. M., Wrasidlo, W. A., Reisfeld, R. A. Antibody conjugates with morpholinodoxorubicin and acid-cleavable linkers Bioconjugate Chemistry  1990 1:325-330  DOI:10.1021/bc00005a005  PMID:1711377
    • Mueller, B. M., Reisfeld, R. A., Gillies, S. D. Serum half-life and tumor-localization of a chimeric antibody deleted of the ch2 domain and directed against the disialoganglioside-gd2 Proceedings of the National Academy of Sciences of the United States of America  1990 87:5702-5705  DOI:10.1073/pnas.87.15.5702  PMID:2198570
    • Mueller, B. M., Romerdahl, C. A., Gillies, S. D., Reisfeld, R. A. Enhancement of antibody-dependent cytotoxicity with a chimeric anti-gd2 antibody Journal of Immunology  1990 144:1382-1386  PMID:2303711
    • Hank, J. A., Robinson, R. R., Surfus, J., Mueller, B. M., Reisfeld, R. A., Cheung, N. K., Sondel, P. M. Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2 Cancer Research  1990 50:5234-5239  PMID:2386933
    • Mueller, B. M., Wrasidlo, W. A., Reisfeld, R. A. Determination of the number of epsilon-amino groups available for conjugation of effector molecules to monoclonal-antibodies Hybridoma  1988 7:453-456  DOI:10.1089/hyb.1988.7.453  PMID:3143663

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support